To test the necessity of c-Met activation in acquisition of high glucose induced aggressive phenotype in HCC, we performed a set of experiments by inhibiting c-Met activity with a c-Met specific small molecule inhibitor, SU11274. This evidence concerns the gene MET and hepatocellular carcinoma.